Acute promyelocytic leukemia (APL) patients with PLZF/RARA fusion protein are largely resistant to all-trans retinoic acid (ATRA) treatment and with poor prognosis [90]. The gene discussed is RARA; the disease is acute promyelocytic leukemia.